The majority of patients experience significant weight regain if treatment with GLP-1 medications stops, and it is unclear if there will be a sustainable, long-term access to GLP-1 treatment for obesity for Medicare beneficiaries. Nielsen says she anticipates demand for the GLP-1 Bridge program will be high, making it important to see your healthcare provider for an evaluation now
Furthermore, GHK-Cu has demonstrated neuroprotective properties and can promote the growth of new neurites, potentially enhancing cognitive function and protecting against age-related decline
Obstructive sleep apnea is directly linked to daytime somnolence, cognitive impairment, and decreased quality of life, and has been associated with broader health conditions, including high blood pressure, heart attacks, heart failure, and diabetes
Because it is so central to cellular health, maintaining optimal levels is often a priority for those looking to support their immune system and healthy aging
2 In this study, following 36 weeks of therapy with once weekly SC tirzepatide (10 or 15 mg), participants (n = 670) were randomized to continue tirzepatide or switch to placebo for an additional 52 weeks